P3 Health Partners Inc.是一家特許公司,總部位於特拉華州(以下簡稱“公司”),已授予下面列出的參與者(“參與者根據P3 Health Partners Inc. 2021激勵獎勵計劃(隨時修訂的「計劃」)和附上的限制性股票單位協議描述的限制性股票單位(“RSUs支付)在本限制性股票單位授予通知書(本“期權授予通知”),根據P3 Health Partners Inc. 2021激勵獎勵計劃(隨時修訂的「計劃」)和附上的限制性股票單位協議計劃” 附件A (「本登記聲明」) 由特立軟件股份有限公司,一家德拉華州股份公司 (以下簡稱爲「本公司」) 提交,目的是爲了註冊其額外的7,184,563股A類普通股,每股面值$0.0001 (以下簡稱爲「A類普通股」), 以及在特立軟件股份有限公司 2022年股權激勵計劃下可發行股份的1,436,911股A類普通股,注(下文簡稱爲「A類普通股」)。協議此發放通知中涉及的”),均已納入本發放通知的參考之中。未在本發放通知或協議中明確定義的大寫字母術語,按照計劃中所給予的含義解釋。
“合格的控制權變更” 意味着控股權變更(如計劃中定義的),但不包括一項交易或一系列交易,其後芝加哥太平洋創始基金有限合夥企業及其關聯方(統稱爲“CPF”) beneficially own securities of the Company (or its successor entity) possessing the largest total combined voting power of the Company’s or its successor entity’s securities outstanding immediately after such transaction or series of transactions, or (ii) pursuant to which any 「group」 that includes CPF directly or indirectly acquires beneficial ownership of securities of the Company (or its successor entity) possessing a majority of the total combined voting power of the Company or its successor entity after such acquisition (either of (i) or (ii), a “CPF Transaction”).
2
By accepting (whether in writing, electronically or otherwise) the RSUs, Participant agrees to be bound by the terms of this Grant Notice萬億.e Plan and the Agreement. Participant has reviewed the Plan, this Grant Notice and the Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of the Plan, this Grant Notice and the Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, this Grant Notice or the Agreement.